Inflammation and Late-Life Depressive Symptoms: Inflammation et symptômes dépressifs chez les personnes âgées
The Canadian Journal of Psychiatry · 21.11.2026
DOI: 10.1177/07067437261500819 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Canadian Journal of Psychiatry, online erschienen am 21.11.2026. Verfasst von Malcolm Forbes und 12 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
Background
Low-level systemic inflammation has been associated with late-life depressive symptoms. Whether individuals with higher inflammation derive preventive benefit from low-dose aspirin therapy is unknown.
Methods
We performed a post-hoc analysis of the ASPirin in Reducing Events in the Elderly (ASPREE) randomized, double-blind, placebo-controlled trial. Baseline high-sensitivity C-reactive protein (hsCRP) was measured in plasma and depressive symptoms were assessed annually using the Center for Epidemiologic Studies Depression 10 Scale (CES-D-10), with elevated symptoms defined as CES-D-10 ≥ 8. Participants with elevated depressive symptoms at baseline were excluded. We fitted population-averaged logistic generalized estimating equation models adjusted for baseline sociodemographic and lifestyle covariates, including an hsCRP × treatment interaction to test effect modification by aspirin.
Results
Higher baseline hsCRP was associated with increased odds of elevated depressive symptoms during follow-up (OR 1.07 per SD increase in hsCRP, 95% CI 1.03–1.11). Low-dose aspirin allocation did not modify the hsCRP-depressive symptoms association (interaction OR 1.02, 95% CI 0.94–1.10). Findings were similar after additional adjustment for comorbidity and other covariates.
Conclusions
In community-dwelling older adults during the ASPREE randomized trial period, higher baseline hsCRP was modestly associated with elevated depressive symptoms. There was no evidence that low-dose aspirin was associated with reduced risk of depressive symptoms among participants with higher baseline inflammation.
Zitieren
APA
Forbes, M., Lotfaliany, M., Mengist, B., Isvoranu, A., Yu, C., Lacaze, P., Kang, M., Nguyen, T., Woods, R. L., McNeil, J. J., Neumann, J. T., Mohebbi, M., & Berk, M. (2026). Inflammation and Late-Life Depressive Symptoms: Inflammation et symptômes dépressifs chez les personnes âgées. The Canadian Journal of Psychiatry. https://doi.org/10.1177/07067437261500819
Vancouver
Forbes M, Lotfaliany M, Mengist B, Isvoranu A, Yu C, Lacaze P, et al. Inflammation and Late-Life Depressive Symptoms: Inflammation et symptômes dépressifs chez les personnes âgées. The Canadian Journal of Psychiatry. 2026. doi:10.1177/07067437261500819
BibTeX
@article{Forbes2026,
author = {Forbes, Malcolm and Lotfaliany, M. and Mengist, B. and Isvoranu, A-M. and Yu, C. and Lacaze, P. and Kang, M. and Nguyen, T. and Woods, R. L. and McNeil, J. J. and Neumann, J. T. and Mohebbi, M. and Berk, M.},
title = {Inflammation and Late-Life Depressive Symptoms: Inflammation et symptômes dépressifs chez les personnes âgées},
journal = {The Canadian Journal of Psychiatry},
year = {2026},
doi = {10.1177/07067437261500819}
}
EUVIMED